Department of Psychology, University at Buffalo, Suny, Buffalo, NY, USA.
Department of Internal Medicine and Health Behavior, Roswell Park Cancer Institute, Buffalo, NY, USA.
Nicotine Tob Res. 2022 Nov 12;24(12):1914-1920. doi: 10.1093/ntr/ntac187.
Although treatment outcome expectancies (TOEs) may influence clinical outcomes, TOEs are rarely reported in the smoking cessation literature, in part because of the lack of validated measures. Therefore, we conducted a psychometric evaluation of TOEs scores with the Stanford Expectations of Treatment Scale (SETS) in the context of a smoking cessation clinical trial.
Participants were 320 adults enrolled in a randomized controlled trial of extended versus standard pre-quit varenicline treatment for smoking cessation (clinicaltrials.gov ID: NCT03262662). Across an 8-week treatment period, we examined the nature and stability of the factor structure using confirmatory factor analysis (CFA), evaluated discriminant validity by examining correlations with abstinence self-efficacy and positive/negative affect (PA/NA), and assessed internal consistency and test-retest reliability of SETS scores.
CFAs supported a 2-factor structure that was stable (ie, invariant) across weeks. Positive and negative TOEs were each reflected in three-item subscales that exhibited acceptable to excellent internal consistency (Cronbach's alphas ≥ .77). Positive and negative TOEs were modestly correlated with PA and NA (all |rs| <.27, p < .05). Positive TOEs, but not negative TOEs, were moderately correlated with abstinence self-efficacy (rs = .45 to .61, p < .01). Both positive and negative TOEs scores demonstrated moderate test-retest reliability between assessments (rs = .54 to .72).
SETS scores generally reflect a valid and reliable assessment of positive and negative TOEs in a sample of adults enrolled in a smoking cessation trial. The SETS appears to be a reasonable option for assessing TOEs in future smoking treatment studies.
Assessments of treatment outcome expectancies are rarely reported in the smoking cessation literature. The present results support the validity and reliability of the SETS scores among adults seeking treatment for their smoking behavior.
尽管治疗期望(TOE)可能会影响临床结果,但在戒烟文献中很少报告 TOE,部分原因是缺乏经过验证的测量方法。因此,我们在一项戒烟临床试验中使用斯坦福治疗期望量表(SETS)对 TOE 评分进行了心理计量学评估。
共有 320 名参加延长与标准戒烟前伐伦克林治疗的随机对照试验的成年人(clinicaltrials.gov ID:NCT03262662)参与了该研究。在 8 周的治疗期间,我们通过验证性因素分析(CFA)检查了因素结构的性质和稳定性,通过检查与戒烟自我效能和正负性情绪(PA/NA)的相关性来评估判别效度,并评估了 SETS 评分的内部一致性和重测信度。
CFA 支持了一个在整个星期内稳定(即不变)的 2 因素结构。积极和消极的 TOE 分别反映在三个项目的子量表中,具有可接受至优秀的内部一致性(Cronbach 的 α 值≥.77)。积极和消极的 TOE 与 PA 和 NA 适度相关(所有 |rs| <.27,p <.05)。积极的 TOE,但不是消极的 TOE,与戒烟自我效能中度相关(rs 值为.45 至.61,p <.01)。积极和消极的 TOE 评分在两次评估之间具有中度重测信度(rs 值为.54 至.72)。
SETS 评分总体上反映了在参加戒烟试验的成年人样本中对积极和消极 TOE 的有效和可靠评估。SETS 似乎是未来吸烟治疗研究中评估 TOE 的合理选择。
在戒烟文献中很少报告治疗期望的评估。本研究结果支持了 SETS 评分在寻求治疗吸烟行为的成年人中的有效性和可靠性。